http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0368520-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5efe48cd77a93f961361bebaf1c08b56
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q5-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q5-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042
filingDate 1990-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af21f24f368533334d206dc7be3879ed
publicationDate 1991-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0368520-A
titleOfInvention Therapeutic agent for reducing steatorrea
abstract PURPOSE: To use 5'-deoxy 5'-methylthioadenosine, etc., for production of pharmaceutical composition for reducing scalp steatorrea and dandruff-like desquamation and pruritus concerning the scalp steatorrea. n CONSTITUTION: This therapeutic agent for reducing steatorrea includes 5'- deoxy-5'-methylthioadenosine, S-adenosylmethionine and a salt thereof. The composition applicable as constitutional administration system includes 50-1600mg, preferably 600-1200mg active ingredient, and the composition for topical administration includes 0.2-16wt.%, preferably 2-8wt.% active ingredient with a pharmaceutical additive and vehicle in combination. n COPYRIGHT: (C)1991,JPO
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2014163152-A1
priorityDate 1989-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226476574
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9865603
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226476573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54518355
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226476572
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54063168
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226476571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226523654
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226441389
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID688097
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20056725
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57104771
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24762165
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411059422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226819447
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71431122
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID34756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419488605

Total number of triples: 49.